NexPoint Life Sciences DST
NexPoint Life Sciences DST is a real estate fund based in Dallas, Texas. According to its most recent Form D, filed Jun 6, 2022, it has sold $104,959,651 of interests to 236 investors since its first sale in Dec 2021. The minimum investment it accepts from an outside investor is $100,000. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include NREA Casper, LLC; Matt McGraner; Matthew Goetz.
- Total raised
- $104,959,651Cumulative sales reported on Form D
- Investors
- 236
- First sale
- Dec 16, 2021
- Minimum investment
- $100,000
- Who can invest
- Not stated
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- NREA Casper, LLC; Matt McGraner; Matthew Goetz
- Latest Form D
- Jun 6, 2022
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about NexPoint Life Sciences DST
What is the minimum investment for NexPoint Life Sciences DST?
According to its latest Form D, filed Jun 6, 2022, the minimum investment NexPoint Life Sciences DST accepts from an outside investor is $100,000.
Who can invest in NexPoint Life Sciences DST?
NexPoint Life Sciences DST is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(b), which does not allow general advertising.
How much has NexPoint Life Sciences DST raised?
NexPoint Life Sciences DST reports $104,959,651 sold from 236 investors on its Form D filed Jun 6, 2022. This is cumulative sales since the offering began, not current assets or performance.
Where is NexPoint Life Sciences DST based?
NexPoint Life Sciences DST is based in Dallas, Texas.
When did NexPoint Life Sciences DST launch?
NexPoint Life Sciences DST reports its first sale in Dec 2021.
Size compared with every real estate fund
Raised more than 99% of the 1,421 real estate funds based in Texas, and more than 97% of all 7,337 that report sales.